Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celite ACT versus kaolin ACT-guided heparin management during cardiopulmonary bypass
NL-OMON29162Recruiting
- Sponsor
- Institutional
- Start
- Jun 2008
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of heparin in None (2 arms), sponsored by Institutional. Primary endpoint: Total heparin use at the end of cardiopulmonary bypass. Started Jun 2008; status: recruiting.
02
Drugs
heparin
Beyond the preview
Go deeper on NL-OMON29162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29162.